Grants
Additional funding opportunities
Research Funding Opportunities
Grants Awarded for Health Sciences Research
| Title | Type | $ Amount | Activity | Investigator | Unit | Sponsor | Date |
|---|---|---|---|---|---|---|---|
| Evaluation of the Accuracy and Efficiency of Utilizing Virtual-Reality Tools to Diagnose Pulmonary Embolism | Grant | $10,000.00 | Research | Jason Lee | Medical Imaging | Society of Thoracic Radiology | 01/2023 |
| Enhancing Early Career Research Ethics to Support Indigenous Research Governance | Grant | $213,003.00 | Research | Stephanie Carroll | Community Environment & Policy | Inter Tribal Council of Arizona, Incorporated | 01/2023 |
| Efficacy of novel compounds to activate GPR143 | Cooperative Agreement | $651.95 | Research | Brian Mckay | Ophthalmology & Vision Science | FELIQS Corporation | 01/2023 |
| Early in vivo expressed antigens and their role in virulence, immune responses and vaccines for Coccidioidomycosis | Contract | $315,685.00 | Research | Kenneth Knox | COM Phx Internal Medicine | Northern Arizona University | 01/2023 |
| Community Settings Approach to Prevention and Education of Diabetes | Grant | $137,991.00 | Research | Kelly Palmer | UAHS Research | American Diabetes Association | 01/2023 |
| Construction of the Center for the Center for Advanced Molecular and Immunological Therapies, (CAMI) Building | Contract | $150,000,000.00 | Other Sponsored Activity | Michael Dake | UAHS Research | Office of the Arizona Governor | 01/2023 |
| Responsible Adult Marijuana Use Education and Outreach | Contract | $287,510.00 | Instruction | Benjamin Brady | Comp Pain and Addiction Ctr | Arizona Department of Health Services | 01/2023 |
| The Use of Povidone-Iodine Sterile Solution To Reduce Periprosthetic Joint Infections: A Superiority Multicentre Randomized Trial | Contract | $35,698.00 | Clinical Trial | Joseph Walker | COM Phx Orthopedics | Center for Innovation and Research Organization, LLC | 01/2023 |
| Non-Hodgkin Lymphoma: Epcoritamab in Combination with Anti-Neoplastic Agents | Contract | $935,073.00 | Clinical Trial | Abhijeet Kumar | Cancer Center Division | AbbVie Incorporated | 01/2023 |
| Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group, Polysomnography, Dose-finding Study Assessing the Efficacy, Safety, and Pharmacokinetics of Multiple-dose Oral Administratio | Contract | $405,335.48 | Clinical Trial | Daniel Combs | Pediatrics | Idorsia Pharmaceutical (Switzerland) | 01/2023 |
| Effect of Continuous Renal Replacement Therapy and Residual Renal Clearance on Cefiderocol Pharmacokinetics in Critically IllAdult Patients | Contract | $41,209.00 | Clinical Trial | Nelson Nicolasora | COM Phx Internal Medicine | Hartford Hospital | 01/2023 |
| Edwards EVOQUE Transcatheter Tricuspid Valve Replacement: Pivotal Clinical Investigation of Safety and Clinical Efficacy using a Novel Device | Contract | $1,472,799.00 | Clinical Trial | Marvin Eng | COM Phx Internal Medicine | Edwards Lifesciences LLC | 01/2023 |
| COVID-19 Neuro Databank/Biobank | Contract | $11,100.00 | Clinical Trial | Joyce Lee-Iannotti | COM Phx Neurology | New York University | 01/2023 |
| AbatacepT foR ImmUne Checkpoint Inhibitor Associated Myocarditis (ATRIUM): A Phase 3, Investigator-Initiated, Randomized, Double- Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of | Contract | $205,530.52 | Clinical Trial | Farouk Mookadam | COM Phx Internal Medicine | Massachusetts General Hospital | 01/2023 |
| A Randomized, Double-Blind, Placebo-Controlled, Phase 2, 6-Month Study to Evaluate the Safety, Tolerability and Exploratory Efficacy of CT1812 in Subjects with Mild to Moderate Dementia with Lewy Bodi | Contract | $287,597.00 | Clinical Trial | Scott Sherman | Neurology | Synteract HCR | 01/2023 |
| A Randomized Phase II Study of Atezolizumab and A Randomized Phase II Study of Atezolizumab and Bevacizumab with Y90 TARE in Patients with Unresectable Hepatocellular Carcinoma (HCC), HCRN GI19-405 | Contract | $112,864.40 | Clinical Trial | Gregory Woodhead | Cancer Center Division | Hoosier Cancer Research Network, Inc. | 01/2023 |
| A Phase 3, Randomized, Double-blind, Placebo-Controlled, Multicenter Study of Upifitamab Rilsodotin (XMT-1536) as Post-Platnum Maintenance Therapy for Participants with Recurrent, Platinum-Sensitive | Contract | $217,609.28 | Clinical Trial | Setsuko Chambers | Cancer Center Division | GOG Foundation, Inc. | 01/2023 |
| A Phase 3, Multicenter, Prospective, Randomized, Double-blind Study of Two Treatment Regimens for Candidemia and/or Invasive Candidiasis: Intravenous Echinocandin followed by Oral Ibrexafungerp versus | Contract | $243,322.56 | Clinical Trial | Mohanad Al-Obaidi | Medicine | SCYNEXIS, Inc. | 01/2023 |
| A Phase 2 Open-label Study of Loncastuximab Tesirine in Combination with Rituximab (Lonca-R) in Previously Untreated Unfit/Frail Patients with Diffuse Large B-cell Lymphoma (DLBCL) (LOTIS-9) | Contract | $188,634.56 | Clinical Trial | Abhijeet Kumar | Cancer Center Division | Pharmaceutical Research Associates | 01/2023 |
| A Phase 1, Multi-center, Open Label First-in-Human Study with ABBV-CLS-579 Alone and in Combination in Subjects with Locally Advanced or Metastatic Tumors | Contract | $830,548.63 | Clinical Trial | Jennifer Segar | Cancer Center Division | AbbVie Incorporated | 01/2023 |
| The Single Intravenous Dose Effect of EDGEWISE# in Cats with Hypertrophic Cardiomyopathy | Grant | $17,695.00 | Research | Samantha Harris | Cellular & Molecular Medicine | University of California, Davis | 12/2022 |
| Targeting CXCL10 Chemokine Signaling in Breast Cancer Metastasis | Grant | $153,500.00 | Research | Suwon Kim | COM Phx Basic Medical Sci | National Cancer Institute | 12/2022 |
| SMARTer Training: A Data-Driven, Collaborative Toolkit to Improve Training and Reporting Outcomes for Contractors and Small Mine Operators | Grant | $157,936.00 | Research | Leonard Brown | Community Environment & Policy | United States Department of Labor | 12/2022 |
| Preclinical Development of a Novel eNAMPT-Neutralizing mAb for Pulmonary Hypertension | Grant | $148,589.00 | Research | Mohamed Ahmed | Pediatrics | Aqualung Therapeutics, Corp. | 12/2022 |
| Plant Exosomes-like Vesicles for Radiomitigator Countermeasures Delivery | Grant | $147,023.00 | Research | Frederic Zenhausern | COM Phx NanoBioscience & Med | Columbia University | 12/2022 |